US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by eXoZymes Inc.

News headline image
Bringing clarity and precision to the cell-free space by introducing exozymes
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
News headline image
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
News headline image
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
News headline image
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
News headline image
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
News headline image
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ
News headline image
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
From eXoZymes Inc.
Via GlobeNewswire
Tickers EXOZ MDBH
News headline image
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
From eXoZymes Inc.
Via GlobeNewswire
Tickers IZTC MDBH